Tropane-Based Ibogaine Analog Rescues Folding-Deficient Serotonin and Dopamine Transporters
- 28 August 2020
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Pharmacology & Translational Science
- Vol. 4 (2) , 503-516
Abstract
Missense mutations that give rise to protein misfolding are rare, but collectively, defective protein folding diseases are consequential. Folding deficiencies are amenable to pharmacological correction (pharmacochaperoning), but the underlying mechanisms remain enigmatic. Ibogaine and its active metabolite noribogaine correct folding defects in the dopamine transporter (DAT), but they rescue only a very limited number of folding-deficient DAT mutant proteins, which give rise to infantile Parkinsonism and dystonia. Herein, a series of analogs was generated by reconfiguring the complex ibogaine ring system and exploring the structural requirements for binding to wild-type transporters, as well as for rescuing two equivalent synthetic folding-deficient mutants, SERT-PG601,602AA and DAT-PG584,585AA. The most active tropane-based analog (9b) was also an effective pharmacochaperone in vivo in Drosophila harboring the DAT-PG584,585AA mutation and rescued 6 out of 13 disease-associated human DAT mutant proteins in vitro. Hence, a novel lead pharmacochaperone has been identified that demonstrates medication development potential for patients harboring DAT mutations.Keywords
All Related Versions
Funding Information
- Vienna Science and Technology Fund (LSC17-026)
This publication has 47 references indexed in Scilit:
- Nonclassical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators, and Partial SubstratesThe Journal of Pharmacology and Experimental Therapeutics, 2013
- The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine TransportersJournal of Biological Chemistry, 2012
- Studies of the Biogenic Amine Transporters. 14. Identification of Low-Efficacy “Partial” Substrates for the Biogenic Amine TransportersThe Journal of Pharmacology and Experimental Therapeutics, 2012
- Dopamine Modulates Metabolic Rate and Temperature Sensitivity in Drosophila melanogasterPLOS ONE, 2012
- Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental studyThe Lancet Neurology, 2011
- Mutations in the Carboxyl-terminal SEC24 Binding Motif of the Serotonin Transporter Impair Folding of the TransporterJournal of Biological Chemistry, 2010
- The N Terminus of Monoamine Transporters Is a Lever Required for the Action of AmphetaminesJournal of Biological Chemistry, 2010
- pySolo: a complete suite for sleep analysis in DrosophilaBioinformatics, 2009
- Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylaseJournal of Neurobiology, 2003
- Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotoninLife Sciences, 1995